Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: September & October Licensing revenues total at least $1M

Per the 10q, as of October 9, PDS has $2.9M in cash balance. That's up from $1.9 in cash as of 8/31. That should mean that "at least" $1M in license revenue came in and logically more, since PDS will have had to have had expenses since 8/31 that it had to pay (advances to Alliacense, expert testimony bills, legal fees, etc.). It's unclear to me whether the $958K HTC award would be accounted for yet, though, in that $2.9M amount

With that in mind, that would give us an idea of the amounts received from Amazon and Acer. The Kyrocera fee should be part or the $1.49M that was reported for last quarter.

The question in my mind would be about the additional licenses that might have been signed that have never been announced, but that may be reflected in the $1.49M or the "at least $1M" amounts.

Share
New Message
Please login to post a reply